NCT03159741View on ClinicalTrials.gov

Investigation of GLP-2 Mechanism of Action (GA-8)

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 16, 2017

Primary Completion Date

September 29, 2017

Study Completion Date

September 29, 2017

Conditions
Healthy
Interventions
OTHER

Inhibitor + GLP-2

Inhibitor and GLP-2 are used as study tools.

OTHER

Placebo + GLP-2

Placebo and GLP-2 are used as study tools.

OTHER

Placebo + GIP

Placebo and GIP are used as study tools.

OTHER

Placebo + Saline

Placebo

Trial Locations (1)

2650

Hvidovre University Hospital, Hvidovre

All Listed Sponsors
collaborator

Hvidovre University Hospital

OTHER

lead

University of Copenhagen

OTHER

NCT03159741 - Investigation of GLP-2 Mechanism of Action (GA-8) | Biotech Hunter | Biotech Hunter